A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment (Q44014994)
scientific article published in June 2002
Language:
(P31) (Q13442814)
(P304) 1526-1530
(P407) (Q1860)
(P433) 11
(P478) 165
(P577) Saturday, June 1, 2002
(P921) (Q12204)
(Q3935297)
(Q423169)
(P1433) (Q4744267)
(P1476) "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" (language: en)
(P2093) Naomi N Bock
Timothy R Sterling
Carol D Hamilton
Connie Pachucki
Yong-Cheng Wang
Donna S Conwell
Ann Mosher
Mary Samuels
Andrew Vernon
Tuberculosis Trials Consortium, Centers for Disease Control and Prevention, Atlanta, Georgia
(P2860) (Q34340511)
(Q43738362)
(Q28248823)
(Q31369223)
(Q45756012)
(Q28364123)
other details
description scientific article published in June 2002

External Links